Daud AI - Search Results

1

Messina JL, Yu H, Riker AI, Munster PN, Jove RL, Daud AI. Messina JL, et al. Among authors: daud ai. Cancer Control. 2008 Jul;15(3):196-201. doi: 10.1177/107327480801500302. Cancer Control. 2008. PMID: 18596671 Free article.

2

Roles of activated Src and Stat3 signaling in melanoma tumor cell growth.

Niu G, Bowman T, Huang M, Shivers S, Reintgen D, Daud A, Chang A, Kraker A, Jove R, Yu H. Niu G, et al. Oncogene. 2002 Oct 10;21(46):7001-10. doi: 10.1038/sj.onc.1205859. Oncogene. 2002. PMID: 12370822

3

Overall and progression-free survival in metastatic melanoma: analysis of a single-institution database.

Khan MA, Andrews S, Ismail-Khan R, Munster PN, Brem S, King J, Reintgen DS, Sondak VK, Daud AI. Khan MA, et al. Among authors: daud ai. Cancer Control. 2006 Jul;13(3):211-7. doi: 10.1177/107327480601300308. Cancer Control. 2006. PMID: 16885917 Free article.

4

Src activation in melanoma and Src inhibitors as therapeutic agents in melanoma.

Homsi J, Cubitt CL, Zhang S, Munster PN, Yu H, Sullivan DM, Jove R, Messina JL, Daud AI. Homsi J, et al. Among authors: daud ai. Melanoma Res. 2009 Jun;19(3):167-75. doi: 10.1097/CMR.0b013e328304974c. Melanoma Res. 2009. PMID: 19434004

5

Immunotherapy as part of a multidisciplinary approach to melanoma treatment.

Riker AI, Jove R, Daud AI. Riker AI, et al. Among authors: daud ai. Front Biosci. 2006 Jan 1;11:1-14. doi: 10.2741/1775. Front Biosci. 2006. PMID: 16146709 Review.

6

Cutaneous melanoma: prognostic factors.

Homsi J, Kashani-Sabet M, Messina JL, Daud A. Homsi J, et al. Cancer Control. 2005 Oct;12(4):223-9. doi: 10.1177/107327480501200403. Cancer Control. 2005. PMID: 16258493 Free article. Review.

7

Valproic acid alters chromatin structure by regulation of chromatin modulation proteins.

Marchion DC, Bicaku E, Daud AI, Sullivan DM, Munster PN. Marchion DC, et al. Among authors: daud ai. Cancer Res. 2005 May 1;65(9):3815-22. doi: 10.1158/0008-5472.CAN-04-2478. Cancer Res. 2005. PMID: 15867379

8

Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor.

Daud AI, Mirza N, Lenox B, Andrews S, Urbas P, Gao GX, Lee JH, Sondak VK, Riker AI, Deconti RC, Gabrilovich D. Daud AI, et al. J Clin Oncol. 2008 Jul 1;26(19):3235-41. doi: 10.1200/JCO.2007.13.9048. J Clin Oncol. 2008. PMID: 18591558 Clinical Trial.

9

Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.

Daud AI, DeConti RC, Andrews S, Urbas P, Riker AI, Sondak VK, Munster PN, Sullivan DM, Ugen KE, Messina JL, Heller R. Daud AI, et al. J Clin Oncol. 2008 Dec 20;26(36):5896-903. doi: 10.1200/JCO.2007.15.6794. Epub 2008 Nov 24. J Clin Oncol. 2008. PMID: 19029422 Free PMC article. Clinical Trial.

10

Uncommon manifestations of common malignancies: case 3. Malignant melanoma arising from a spinal nerve root.

Naing A, Messina JL, Vrionis FR, Daud AI. Naing A, et al. Among authors: daud ai. J Clin Oncol. 2004 Aug 1;22(15):3194-5. doi: 10.1200/JCO.2004.09.021. J Clin Oncol. 2004. PMID: 15284274 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters